# Twist Bioscience Corporation (TWST) FY2026 Q3 P&L / Income Statement

- Company: Twist Bioscience Corporation (TWST)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q3 FY2026 10-Q, filed 2026-08-03, accession number 0001581280-26-000047
- Page: https://plicit.ai/financials/twst/fy2026-q3-income-statement
- Chart image: https://plicit.ai/charts/twst-fy2026-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 118,376,000 US dollars
- **Cost of revenues**: 55,922,000 US dollars
- **Gross profit (calculated)**: 62,454,000 US dollars
- **Operating expenses (calculated)**: 98,734,000 US dollars
- **Loss from operations**: negative 36,280,000 US dollars
- **Other income (expense), net (calculated)**: 1,540,000 US dollars
- **Income (loss) before income taxes**: negative 34,740,000 US dollars
- **Income tax expense**: 311,000 US dollars
- **Net (loss) income**: negative 35,051,000 US dollars
- **DNA synthesis and protein solutions**: 56,571,000 US dollars
- **NGS applications**: 61,805,000 US dollars
- **Research and development expenses**: 18,025,000 US dollars
- **Selling, general and administrative expenses**: 80,709,000 US dollars
- **Litigation settlement costs, net of recoveries**: 0 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/twst/fy2026-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/twst-fy2026-q3-revenue-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 118,376,000 US dollars
- **Cost of revenues**: 55,922,000 US dollars
- **Gross profit (calculated)**: 62,454,000 US dollars
- **Operating expenses (calculated)**: 98,734,000 US dollars
- **Loss from operations**: negative 36,280,000 US dollars
- **Other income (expense), net (calculated)**: 1,540,000 US dollars
- **Income (loss) before income taxes**: negative 34,740,000 US dollars
- **Income tax expense**: 311,000 US dollars
- **Net (loss) income**: negative 35,051,000 US dollars
- **Americas**: 77,259,000 US dollars
- **EMEA**: 33,622,000 US dollars
- **Asia Pacific**: 7,495,000 US dollars
- **Research and development expenses**: 18,025,000 US dollars
- **Selling, general and administrative expenses**: 80,709,000 US dollars
- **Litigation settlement costs, net of recoveries**: 0 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Industry Sectors

- Page: https://plicit.ai/financials/twst/fy2026-q3-income-statement/revenue-by-industry-sectors
- Chart image: https://plicit.ai/charts/twst-fy2026-q3-revenue-by-industry-sectors-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Industry Sectors. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 118,376,000 US dollars
- **Cost of revenues**: 55,922,000 US dollars
- **Gross profit (calculated)**: 62,454,000 US dollars
- **Operating expenses (calculated)**: 98,734,000 US dollars
- **Loss from operations**: negative 36,280,000 US dollars
- **Other income (expense), net (calculated)**: 1,540,000 US dollars
- **Income (loss) before income taxes**: negative 34,740,000 US dollars
- **Income tax expense**: 311,000 US dollars
- **Net (loss) income**: negative 35,051,000 US dollars
- **Therapeutics**: 40,413,000 US dollars
- **Diagnostics**: 43,843,000 US dollars
- **Industry and applied**: 5,749,000 US dollars
- **Academic research and government**: 15,512,000 US dollars
- **Global supply partners**: 12,859,000 US dollars
- **Research and development expenses**: 18,025,000 US dollars
- **Selling, general and administrative expenses**: 80,709,000 US dollars
- **Litigation settlement costs, net of recoveries**: 0 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.